| Origin | Human | |
| Antibody | ||
| Nomenclature | ||
| PDB Code | 4FOC | |
| Resolution (Å) | 1.7 | |
| Reference | Lewis, R.T., Bode, C.M., Choquette, D.M., Potashman, M., Romero, K., Stellwagen, J.C., Teffera, Y., Moore, E., Whittington, D.A., Chen, H., Epstein, L.F., Emkey, R., Andrews, P.S., Yu, V.L., Saffran, D.C., Xu, M., Drew, A., Merkel, P., Szilvassy, S., Brake, R.L The discovery and optimization of a novel class of potent, selective, and orally bioavailable anaplastic lymphoma kinase (ALK) inhibitors with potential utility for the treatment of cance J.Med.Chem. 55: 6523-6540, (2012), 10.1021/jm3005866 | |
💡 Mouse: rotation | Scroll wheel: zoom
Styles:
💡 Mouse: rotation | Scroll wheel: zoom
Styles: